{"log_id": 1919051254596195484, "direction": 0, "words_result_num": 98, "words_result": [{"probability": {"variance": 0.004636, "average": 0.981312, "min": 0.57352}, "location": {"width": 1067, "top": 101, "height": 62, "left": 81}, "words": "逆的无意识性运动障碍综合征。尽管该综合征在老消失;然而,某些患者尽管停用了可疑药物仍需继"}, {"probability": {"variance": 0.004596, "average": 0.982592, "min": 0.651529}, "location": {"width": 661, "top": 133, "height": 53, "left": 81}, "words": "年人(尤其是老年女性)中的发生最高,但不续降糖治疗"}, {"probability": {"variance": 0.000324, "average": 0.992157, "min": 0.919913}, "location": {"width": 520, "top": 159, "height": 49, "left": 83}, "words": "能在抗精神病治疗初期仅依据流行病学估计来预测"}, {"probability": {"variance": 0.00015, "average": 0.995819, "min": 0.94046}, "location": {"width": 803, "top": 178, "height": 51, "left": 83}, "words": "哪些患者可能会发生该综合征。不清楚抗精神病药【孕妇及哺乳期妇女用药"}, {"probability": {"variance": 0.004382, "average": 0.977907, "min": 0.744967}, "location": {"width": 467, "top": 207, "height": 44, "left": 84}, "words": "在引起迟发性运动障碍作用方面是否存在差异"}, {"probability": {"variance": 0.000797, "average": 0.989673, "min": 0.891025}, "location": {"width": 478, "top": 189, "height": 46, "left": 672}, "words": "尚未在怀孕妇女中进行适当的并且控制良好的"}, {"probability": {"variance": 0.000221, "average": 0.995566, "min": 0.906231}, "location": {"width": 1017, "top": 212, "height": 61, "left": 131}, "words": "已经确定随着治疗疗程的延长以及患者服研究。怀孕妇女服用阿立哌唑是否会引起胎儿损害"}, {"probability": {"variance": 0.003393, "average": 0.980292, "min": 0.658744}, "location": {"width": 1062, "top": 233, "height": 65, "left": 85}, "words": "用抗精神病药的总累计剂量的增加,发生迟发性运或影响生殖能力,尚不清楚。对于孕妇,只有当对"}, {"probability": {"variance": 0.000378, "average": 0.993566, "min": 0.886158}, "location": {"width": 1010, "top": 259, "height": 60, "left": 85}, "words": "动障碍的风险及其变成不可逆的可能性也增大。然胎儿的潜在利益高于潜在危险时,才可以使用"}, {"probability": {"variance": 0.000972, "average": 0.98898, "min": 0.878406}, "location": {"width": 523, "top": 295, "height": 48, "left": 85}, "words": "而,在低剂量抗精神病药短暂治疗之后也可能会发"}, {"probability": {"variance": 4e-06, "average": 0.998505, "min": 0.993793}, "location": {"width": 447, "top": 282, "height": 42, "left": 674}, "words": "阿立哌唑对人类阵痛和分娩的影响尚不清楚"}, {"probability": {"variance": 0.014931, "average": 0.951157, "min": 0.548793}, "location": {"width": 285, "top": 325, "height": 43, "left": 83}, "words": "生该综合征,但一般很少见"}, {"probability": {"variance": 0.000139, "average": 0.995867, "min": 0.945565}, "location": {"width": 477, "top": 303, "height": 42, "left": 674}, "words": "阿立哌唑可分泌到哺乳期大鼠的乳汁中。阿立"}, {"probability": {"variance": 0.006233, "average": 0.979342, "min": 0.495411}, "location": {"width": 995, "top": 325, "height": 63, "left": 135}, "words": "尽管该综合征在停止抗精神病治疗后会部分或哌唑及其代谢物是否分泌到大乳汁中,尚不清楚"}, {"probability": {"variance": 0.000364, "average": 0.992598, "min": 0.901515}, "location": {"width": 895, "top": 351, "height": 63, "left": 86}, "words": "完全缓解,但目前对确诊为迟发性运动障碍的病例建议服用阿立哌唑的妇女停止哺乳"}, {"probability": {"variance": 0.000988, "average": 0.988246, "min": 0.841564}, "location": {"width": 668, "top": 383, "height": 49, "left": 85}, "words": "没有已知的治疗方案。然而,抗精神病治疗本身可【儿童用药"}, {"probability": {"variance": 0.005874, "average": 0.978532, "min": 0.636476}, "location": {"width": 507, "top": 412, "height": 43, "left": 89}, "words": "能抑制(或部分抑制)这一综合征的体征和症状"}, {"probability": {"variance": 3e-06, "average": 0.999041, "min": 0.993246}, "location": {"width": 475, "top": 393, "height": 44, "left": 680}, "words": "儿童和青少年患者用药的安全性和有效性尚未"}, {"probability": {"variance": 0.000248, "average": 0.992692, "min": 0.947336}, "location": {"width": 593, "top": 426, "height": 53, "left": 91}, "words": "从而可能掩盖病程的发展。还不清楚症状抑制对综确立"}, {"probability": {"variance": 0.000125, "average": 0.994787, "min": 0.960537}, "location": {"width": 279, "top": 460, "height": 40, "left": 89}, "words": "合征的长期病程是否有影响"}, {"probability": {"variance": 5e-06, "average": 0.998553, "min": 0.993382}, "location": {"width": 128, "top": 450, "height": 27, "left": 642}, "words": "【老年用药】"}, {"probability": {"variance": 0.003006, "average": 0.98185, "min": 0.745883}, "location": {"width": 479, "top": 475, "height": 44, "left": 136}, "words": "基于上述考虑,应用阿立哌唑时应采用一种使"}, {"probability": {"variance": 0.002917, "average": 0.982595, "min": 0.764493}, "location": {"width": 465, "top": 461, "height": 42, "left": 682}, "words": "在上市前临床试验中接受阿立哌唑治疗的795"}, {"probability": {"variance": 0.004768, "average": 0.974283, "min": 0.566609}, "location": {"width": 1049, "top": 481, "height": 63, "left": 91}, "words": "迟发性运动障碍的发生降低到最小的方式。对于罹例患者中,991例(12%)年龄≥65岁789例(10%"}, {"probability": {"variance": 0.003029, "average": 0.979166, "min": 0.714395}, "location": {"width": 1070, "top": 504, "height": 67, "left": 86}, "words": "想慢性疾病的患者,进行长期抗精神病治疗应有所年龄≥75岁991例患者中的大多数88%)被诊断"}, {"probability": {"variance": 4e-06, "average": 0.998118, "min": 0.993557}, "location": {"width": 214, "top": 555, "height": 28, "left": 92}, "words": "保留,这些患者包括"}, {"probability": {"variance": 0.001389, "average": 0.990158, "min": 0.832248}, "location": {"width": 469, "top": 535, "height": 43, "left": 378}, "words": "已知用抗精神病药治疗为阿尔茨海默性痴呆"}, {"probability": {"variance": 9e-06, "average": 0.997879, "min": 0.987325}, "location": {"width": 526, "top": 563, "height": 47, "left": 91}, "words": "有效,(2)可供选择的等效、但潜在伤害性更小的"}, {"probability": {"variance": 0.003179, "average": 0.984995, "min": 0.740095}, "location": {"width": 475, "top": 548, "height": 43, "left": 682}, "words": "阿立哌唑治疗精神分裂症和双相障碍躁狂发作"}, {"probability": {"variance": 7.7e-05, "average": 0.996096, "min": 0.953089}, "location": {"width": 1061, "top": 570, "height": 62, "left": 93}, "words": "治疗不能获得或不适合。在需要长期治疗的患者中,的安慰剂对照试验中未录入足够的年龄在65岁或65"}, {"probability": {"variance": 0.000402, "average": 0.992742, "min": 0.905437}, "location": {"width": 1062, "top": 592, "height": 63, "left": 94}, "words": "应寻求能达到满意疗效的最低治疗剂量和最短治疗岁以上的病例,以至不能确定老年患者对治疗的反"}, {"probability": {"variance": 0.003925, "average": 0.979542, "min": 0.693283}, "location": {"width": 497, "top": 619, "height": 42, "left": 637}, "words": "应是否不同于年轻受试者。年龄对单剂量15mg阿"}, {"probability": {"variance": 0, "average": 0.996045, "min": 0.996045}, "location": {"width": 21, "top": 621, "height": 18, "left": 1134}, "words": "立"}, {"probability": {"variance": 1.8e-05, "average": 0.998057, "min": 0.981748}, "location": {"width": 424, "top": 634, "height": 40, "left": 93}, "words": "时间。应定期重新评估连续治疗的必要性"}, {"probability": {"variance": 4e-06, "average": 0.99768, "min": 0.994874}, "location": {"width": 116, "top": 660, "height": 29, "left": 334}, "words": "患者出现迟"}, {"probability": {"variance": 0, "average": 0.999286, "min": 0.999286}, "location": {"width": 24, "top": 661, "height": 22, "left": 451}, "words": "发"}, {"probability": {"variance": 2.4e-05, "average": 0.9966, "min": 0.986796}, "location": {"width": 142, "top": 656, "height": 26, "left": 477}, "words": "性运动障碍的"}, {"probability": {"variance": 1.4e-05, "average": 0.997629, "min": 0.989383}, "location": {"width": 142, "top": 651, "height": 26, "left": 639}, "words": "哌唑的药代动"}, {"probability": {"variance": 4e-06, "average": 0.998702, "min": 0.994757}, "location": {"width": 187, "top": 646, "height": 26, "left": 807}, "words": "学没有影响。与年"}, {"probability": {"variance": 0.009398, "average": 0.953768, "min": 0.683053}, "location": {"width": 160, "top": 641, "height": 25, "left": 997}, "words": "轻成人(18≈64"}, {"probability": {"variance": 0.00648, "average": 0.972757, "min": 0.603075}, "location": {"width": 1065, "top": 661, "height": 60, "left": 98}, "words": "体征和症状,应考虑停药。然而某些患者尽管存岁)受试者比较,老年受试者(≥65岁)的阿立哌"}, {"probability": {"variance": 1.9e-05, "average": 0.996903, "min": 0.988704}, "location": {"width": 143, "top": 668, "height": 25, "left": 142}, "words": "如果阿立哌唑"}, {"probability": {"variance": 0, "average": 0.999557, "min": 0.999534}, "location": {"width": 36, "top": 667, "height": 24, "left": 289}, "words": "治疗"}, {"probability": {"variance": 0.002497, "average": 0.975804, "min": 0.817316}, "location": {"width": 467, "top": 697, "height": 44, "left": 98}, "words": "在这一综合征,可能还是需要用阿立哌唑治疗"}, {"probability": {"variance": 0.000282, "average": 0.992821, "min": 0.929265}, "location": {"width": 521, "top": 680, "height": 48, "left": 641}, "words": "唑清除率降低20%,但在精神分裂症患者的人口药"}, {"probability": {"variance": 0.004738, "average": 0.980254, "min": 0.59942}, "location": {"width": 914, "top": 707, "height": 60, "left": 99}, "words": "10.痴呆相关老年痴呆精神病患者的脑血管不良事代动力学分析中没有显示年龄的影响"}, {"probability": {"variance": 1e-06, "average": 0.999196, "min": 0.996125}, "location": {"width": 473, "top": 728, "height": 38, "left": 689}, "words": "对老年阿尔茨海默病相关精神病患者的研究提"}, {"probability": {"variance": 0.000703, "average": 0.989942, "min": 0.869603}, "location": {"width": 1011, "top": 748, "height": 56, "left": 149}, "words": "在痴呆相关精神病的安慰剂对照临床试验中,示,与年轻精神分裂症患者比较,这类人群也许具"}, {"probability": {"variance": 0.000138, "average": 0.99365, "min": 0.965032}, "location": {"width": 165, "top": 754, "height": 27, "left": 98}, "words": "件,包括脑卒中"}, {"probability": {"variance": 0.003476, "average": 0.977767, "min": 0.698245}, "location": {"width": 1065, "top": 769, "height": 60, "left": 99}, "words": "阿立哌唑治疗老年患者(平均年龄:84岁;年龄范有不同的耐受性。阿立哌唑在阿尔茨海默病相关精"}, {"probability": {"variance": 0.0047, "average": 0.976669, "min": 0.629425}, "location": {"width": 1065, "top": 791, "height": 60, "left": 99}, "words": "围:78~88岁)的脑血管不良事件如脑卒中、短神病患者中的安全性和有效性尚未确立如果医生"}, {"probability": {"variance": 0.011086, "average": 0.967854, "min": 0.578799}, "location": {"width": 981, "top": 816, "height": 56, "left": 101}, "words": "暂性缺血发作),包括死亡的发生率升高。固定剂量选择使用阿立哌唑治疗这类患者应慎重"}, {"probability": {"variance": 0.008467, "average": 0.975926, "min": 0.566976}, "location": {"width": 523, "top": 849, "height": 47, "left": 100}, "words": "的试验结果显示阿立哌唑治疗患者中,脑血管不"}, {"probability": {"variance": 1e-06, "average": 0.998937, "min": 0.99678}, "location": {"width": 157, "top": 846, "height": 28, "left": 671}, "words": "药物相互作用】"}, {"probability": {"variance": 4.7e-05, "average": 0.99693, "min": 0.968729}, "location": {"width": 520, "top": 872, "height": 46, "left": 103}, "words": "良事件与药物之间存在具有统计学意义的剂量一反"}, {"probability": {"variance": 0.001755, "average": 0.985483, "min": 0.807848}, "location": {"width": 472, "top": 859, "height": 42, "left": 695}, "words": "鉴于本品主要作用于中枢神经系统,在与其它"}, {"probability": {"variance": 0.001913, "average": 0.983385, "min": 0.762248}, "location": {"width": 1026, "top": 879, "height": 62, "left": 102}, "words": "应关系。阿立哌唑不能用于痴呆相关精神病患者的作用手中枢神经系统的药物和乙醇合用时"}, {"probability": {"variance": 0.009473, "average": 0.940763, "min": 0.570203}, "location": {"width": 518, "top": 900, "height": 48, "left": 651}, "words": "因其拮抗a肾上腺素能受体,做阿立哌唑有可能增"}, {"probability": {"variance": 0, "average": 0.999932, "min": 0.999867}, "location": {"width": 47, "top": 936, "height": 24, "left": 103}, "words": "治疗"}, {"probability": {"variance": 0.021581, "average": 0.942159, "min": 0.503773}, "location": {"width": 191, "top": 952, "height": 28, "left": 109}, "words": "11.高血糖和糖尿病"}, {"probability": {"variance": 0.000319, "average": 0.990808, "min": 0.948299}, "location": {"width": 257, "top": 933, "height": 35, "left": 649}, "words": "强某些抗高血压药的作用"}, {"probability": {"variance": 0.026964, "average": 0.945263, "min": 0.357456}, "location": {"width": 532, "top": 959, "height": 76, "left": 98}, "words": ",有报道显示在非典型抗精神病药治疗的患者"}, {"probability": {"variance": 0.000106, "average": 0.990854, "min": 0.969071}, "location": {"width": 324, "top": 953, "height": 30, "left": 698}, "words": "其它药物影响阿立哌唑的可能性"}, {"probability": {"variance": 0.001421, "average": 0.980372, "min": 0.871338}, "location": {"width": 457, "top": 983, "height": 44, "left": 174}, "words": "些病例高血糖十分严重并伴随酮酸中毒或高"}, {"probability": {"variance": 0.040042, "average": 0.853194, "min": 0.44887}, "location": {"width": 344, "top": 973, "height": 38, "left": 695}, "words": "阿立哌唑不是 CYPIA1 A CYRLA2"}, {"probability": {"variance": 0.010865, "average": 0.959311, "min": 0.438125}, "location": {"width": 1061, "top": 993, "height": 58, "left": 105}, "words": "渗性昏迷或死亡。阿立哌唑治疗患者几乎没有高血CYP2B6、CYP2C8、CYP2C9OYP2C19或CYP2EI"}, {"probability": {"variance": 0.008132, "average": 0.979428, "min": 0.437571}, "location": {"width": 949, "top": 1018, "height": 55, "left": 107}, "words": "糖的报道,尽管很少患者曾用阿立哌唑治疗但不酶的底物。也不进行直接的葡萄糖酸"}, {"probability": {"variance": 0, "average": 0.999521, "min": 0.999368}, "location": {"width": 41, "top": 1017, "height": 22, "left": 1127}, "words": "说明"}, {"probability": {"variance": 0.002781, "average": 0.986268, "min": 0.679148}, "location": {"width": 1069, "top": 1033, "height": 62, "left": 105}, "words": "清楚这些十分有限的经验是否是这种报道很少的唯阿立哌唑与这些酶的抑制剂或诱导剂、或其它因素"}, {"probability": {"variance": 0.000506, "average": 0.98994, "min": 0.894486}, "location": {"width": 901, "top": 1058, "height": 57, "left": 128}, "words": "原因。评估非典型抗精神病药的使用和血糖异常(如吸烟)之间不可能发生相互作用"}, {"probability": {"variance": 0.008232, "average": 0.957157, "min": 0.663492}, "location": {"width": 521, "top": 1094, "height": 45, "left": 109}, "words": "之间的关系十分复杂,原因在于精神分裂症患者中"}, {"probability": {"variance": 0.00652, "average": 0.98095, "min": 0.444381}, "location": {"width": 1066, "top": 1098, "height": 62, "left": 108}, "words": "糖尿病背景的风险可能增加以及普通人群中糖尿病!CYP3A4诱导剂(如卡马西平)可以引起阿立哌唑的"}, {"probability": {"variance": 0.015322, "average": 0.941084, "min": 0.617634}, "location": {"width": 406, "top": 1140, "height": 43, "left": 109}, "words": "的发生率升高1在这些混淆因素的干扰"}, {"probability": {"variance": 0.010104, "average": 0.974356, "min": 0.4462}, "location": {"width": 612, "top": 1123, "height": 46, "left": 561}, "words": "非典型,清除率升高和血药浓度降低。CYP3A4抑制剂(如酮"}, {"probability": {"variance": 0.010317, "average": 0.960815, "min": 0.437414}, "location": {"width": 1070, "top": 1140, "height": 92, "left": 109}, "words": "系病药的使用和高血糖相关不良事件之间的关康唑)或CYP2D6抑制剂(如奎尼氟西汀、帕罗"}, {"probability": {"variance": 4.5e-05, "average": 0.992588, "min": 0.98587}, "location": {"width": 46, "top": 1179, "height": 24, "left": 112}, "words": "抗精"}, {"probability": {"variance": 0.007054, "average": 0.969456, "min": 0.563532}, "location": {"width": 1022, "top": 1164, "height": 62, "left": 159}, "words": "是完全无法弄清。然而,不包括阿立哌唑的流西汀)可以抑制阿立哌唑消除,使血药浓度升高"}, {"probability": {"variance": 7e-06, "average": 0.998239, "min": 0.98874}, "location": {"width": 522, "top": 1202, "height": 48, "left": 114}, "words": "行病学研究提示在这些研究中用非典型抗精神病"}, {"probability": {"variance": 0.003565, "average": 0.980059, "min": 0.709158}, "location": {"width": 473, "top": 1191, "height": 41, "left": 708}, "words": "酮康唑同时服用酮康唑(200mg天,连续14"}, {"probability": {"variance": 0.000189, "average": 0.992648, "min": 0.940112}, "location": {"width": 1061, "top": 1209, "height": 63, "left": 113}, "words": "药治疗的患者治疗中出现高血糖相关不良事件的天)和15mg单剂量阿立哌唑,阿立哌唑及其活性代"}, {"probability": {"variance": 0.002723, "average": 0.981668, "min": 0.689109}, "location": {"width": 1068, "top": 1232, "height": 61, "left": 112}, "words": "风险增加。因为在进行这些研究时阿立哌唑还未上谢物的AUC分别增加63%和77%。没有对更高剂量"}, {"probability": {"variance": 0.014253, "average": 0.955267, "min": 0.572097}, "location": {"width": 514, "top": 1270, "height": 44, "left": 114}, "words": "市,所以不清楚阿立哌唑是否与这种风险增加相关"}, {"probability": {"variance": 0.007149, "average": 0.975449, "min": 0.590145}, "location": {"width": 501, "top": 1255, "height": 47, "left": 678}, "words": "400mg天)的酮康唑进行研究当同时服用酮康"}, {"probability": {"variance": 9.8e-05, "average": 0.994969, "min": 0.948397}, "location": {"width": 1063, "top": 1276, "height": 67, "left": 116}, "words": "在非典型抗精神病药治疗的患者中,没有明确的高唑和阿立哌唑时,应将阿立哌唑的剂量降至常用剂"}, {"probability": {"variance": 0.01654, "average": 0.938494, "min": 0.534132}, "location": {"width": 507, "top": 1299, "height": 45, "left": 661}, "words": "量的一半。顶期其它CYP3A4强抑制剂(伊曲康唑等"}, {"probability": {"variance": 0.018261, "average": 0.944095, "min": 0.411588}, "location": {"width": 1030, "top": 1324, "height": 63, "left": 160}, "words": "对于开始非典型抗精神病药治疗时有糖尿病明有相似的作用,也需相应降低剂量没有对YP3"}, {"probability": {"variance": 0.000964, "average": 0.990758, "min": 0.856389}, "location": {"width": 498, "top": 1363, "height": 43, "left": 119}, "words": "确诊断的患者应定期监测其血糖控制恶化情况"}, {"probability": {"variance": 7.2e-05, "average": 0.995807, "min": 0.963875}, "location": {"width": 495, "top": 1345, "height": 40, "left": 664}, "words": "的弱抑制剂(红霉素、柚子等)进行研究。当"}, {"probability": {"variance": 0.003293, "average": 0.978917, "min": 0.685958}, "location": {"width": 1067, "top": 1362, "height": 70, "left": 118}, "words": "有糖尿病危险因素(如肥胖、糖原病家族史)的患用联合治疗中的CYP3A4抑制剂时,应增加阿立哌唑"}, {"probability": {"variance": 0.000116, "average": 0.995318, "min": 0.953662}, "location": {"width": 614, "top": 1399, "height": 51, "left": 120}, "words": "者应在开始非典型抗精神病药治疗前和治疗期间定的剂量"}, {"probability": {"variance": 0.000686, "average": 0.989937, "min": 0.873992}, "location": {"width": 520, "top": 1427, "height": 45, "left": 122}, "words": "期接受空腹血糖测试。应监测非典型抗精神病药治"}, {"probability": {"variance": 0.00088, "average": 0.990436, "min": 0.858341}, "location": {"width": 470, "top": 1410, "height": 42, "left": 714}, "words": "尼丁:同时服用10mg单剂量阿立哌唑和强力"}, {"probability": {"variance": 0.010121, "average": 0.946388, "min": 0.50975}, "location": {"width": 1028, "top": 1432, "height": 62, "left": 121}, "words": "疗的任何患者的高血糖症状,包括口多尿多CYP2D6抑制剂一奎尼丁(166mg/天,连续13天"}, {"probability": {"variance": 0.005553, "average": 0.973534, "min": 0.647824}, "location": {"width": 1046, "top": 1447, "height": 73, "left": 123}, "words": "食和乏力在非典型抗精神病药治疗期间出现高血阿立哌唑的AUC增加T12%,而其活性代谢物一脱"}, {"probability": {"variance": 0, "average": 0.975946, "min": 0.975946}, "location": {"width": 26, "top": 1457, "height": 24, "left": 1158}, "words": "氢"}, {"probability": {"variance": 9.4e-05, "average": 0.992971, "min": 0.96915}, "location": {"width": 235, "top": 1474, "height": 35, "left": 948}, "words": "当同时服用奎尼丁和阿"}, {"probability": {"variance": 0.007456, "average": 0.975727, "min": 0.446432}, "location": {"width": 1044, "top": 1482, "height": 59, "left": 120}, "words": "糖症状的患者应接受空腹血糖测试。在某些病例中,阿立哌唑的AUC降低35的的剂量降至常用剂量的"}, {"probability": {"variance": 0.000771, "average": 0.991474, "min": 0.844661}, "location": {"width": 781, "top": 1505, "height": 55, "left": 123}, "words": "当停止非典型抗精神病药治疗时高血糖就会自行立哌唑时,应将阿立哌"}], "language": -1}